Inflammation-reducing drug shows no benefit for dry age-related macular degeneration in trial
The drug minocycline, an antibiotic that also decreases inflammation, failed to slow vision loss or expansion of geographic atrophy in people with dry age-related macular degeneration (AMD), according to a phase II clinical ...
Mar 20, 2024
0
1